drugtargetreview.com5d
FDA’s Project Optimus: A new era in oncology drug dosing
Discover how precision medicine and FDA's Project Optimus are transforming clinical trials in oncology drug development.
drugtargetreview.com2d
Obstacles and innovations of macrocyclic drug development
Discover the potential of macrocycles in drug discovery: flexible, cell-permeable molecules targeting undruggable proteins.
drugtargetreview.com3d
The Michael J Fox Foundation for Parkinson’s Research awards grant to Grifols for pioneering study
Grifols has received a $21 million grant from The Michael J. Fox Foundation to fund a pioneering study aimed at identifying early biomarkers for Parkinson’s disease (PD). Grifols has received funding ...
drugtargetreview.com3d
Beyond the Lab: Stem cell research
Download our latest report to discover how stem cell research is revolutionising treatments for chronic diseases, cancer and regenerative medicine. Dear readers, Welcome to our report on the latest ...
drugtargetreview.com6d
Eurofins launches new GMP certification for supplements
Eurofins Healthcare Assurance introduces a GMP certification programme for supplements, helping brands navigate US regulations while improving product safety and quality. Eurofins Healthcare Assurance ...
drugtargetreview.com4d
UVA’s computer models target antibiotics to combat resistance
Researchers at the University of Virginia School of Medicine have developed computer models to create more targeted antibiotics. This approach aims to fight antibiotic resistance by focusing on ...
drugtargetreview.com5d
Bio-Rad introduces mixed-mode resin for biomolecule purification
Bio-Rad has launched Nuvia wPrime 2A Media, a scalable resin designed for biomolecule purification in research and biotherapeutic applications. Bio-Rad Laboratories, a global leader in life science ...